Latest Breaking News On - Contingent value rights agreement - Page 3 : comparemela.com

Form SC 14D9 Rain Oncology Inc Filed by: Rain Oncology Inc

Form SC 14D9 Rain Oncology Inc Filed by: Rain Oncology Inc
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesState of delawareSan franciscoTran nguyenChris tresterAaron davisShalom auerbachStefania wolffConcentra biosciencesAvanish vellankiPardes biosciencesRyana murrBrandenc bernsRobert phillipsJosephine bruceStefani wolf

Theseus Pharmaceuticals Enters into Agreement to Be Acquired by Concentra Biosciences for between $3 90 and $4 05 in Cash per Share Plus a Contingent Value Right

CAMBRIDGE, Mass., Dec. 22, 2023 /PRNewswire/ Theseus Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients through the discovery,.

United kingdomUnited statesTheseus pharmaceuticalsConcentra biosciencesDunn crutcherTheseus pharmaceuticals incPrnewswire theseus pharmaceuticals incGoodwin procterExchange commissionBase priceContingent value rights agreementTheseu boardTang capital partnersMerger agreementPrivate securities litigation reform actRecommendation statement

I 80 Gold : NOTICE TO SHAREHOLDERS - Form 6-K -November 01, 2023 at 05:07 pm EDT

NOTICE TO SHAREHOLDERS For The Three and Nine Months Ended September 30, 2023 i-80 Gold Corp MANAGEMENT S RESPONSIBILITY FOR.

United statesRuby hillGranite creek mineEsmeralda countyRuby hill mineState of nevadaUnited kingdomEureka countyGranite creekLongstaffschwartx montecarloEwan downieMonte carloK murphy noceto phillipsWaterton global resource management incYork stock exchangeNewmont united states

Zynerba Pharmaceuticals : Acquisition/Asset Disposal - Form 8-K -October 11, 2023 at 08:21 am EDT

Item 2.01. Completion of Acquisition or Disposition of Assets. On October 10, 2023, Harmony Biosciences.

New yorkUnited statesState of delawareParent the surviving corporationCorporation law of the state delawareZynerba pharmaceuticals incCompanya company restricted stock awardCompany restricted stock awardXylophone acquisition corpCompany restricted stockCompany optionsHarmony biosciences holdings incExchange commissionEquiniti trust companyCompany the mergerHarmony biosciences holdings

Kyowa Kirin Co , Ltd (TSE:4151) entered into a Transaction Agreement to acquire Orchard Therapeutics plc (NasdaqCM -October 04, 2023

Kyowa Kirin Co., Ltd. entered into a Transaction Agreement to acquire Orchard Therapeutics plc from RA Capital Management, L.P., Deep Track Capital, LP, Zentree Investment Management Pte. Ltd. and.

United statesUnited kingdomGoldman sachs japan co ltdCompany ordinaryGuggenheim securitiesHigh courtMorrison foerster llpCompany shareholder resolutionsSlaughter may ltdGoodwin procterMorrison foersterCompany ordinary shareKyowa kirin co ltdTransaction agreementOrchard therapeuticsDeep track capital